New Universal Science and Technology Co., Ltd.
SZSE:300472.SZ
9.11 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 233.987 | 567.359 | 684.406 | 442.756 | 485.881 | 535.724 | 302.856 | 219.083 | 214.272 | 192.262 | 173.489 | 163.284 | 127.305 |
| Cost of Revenue
| 194.188 | 382.006 | 466.609 | 308.698 | 307.984 | 345.908 | 202.443 | 141.074 | 144.967 | 114.224 | 105.625 | 102.38 | 79.624 |
| Gross Profit
| 39.799 | 185.353 | 217.797 | 134.058 | 177.898 | 189.816 | 100.413 | 78.008 | 69.305 | 78.038 | 67.864 | 60.905 | 47.68 |
| Gross Profit Ratio
| 0.17 | 0.327 | 0.318 | 0.303 | 0.366 | 0.354 | 0.332 | 0.356 | 0.323 | 0.406 | 0.391 | 0.373 | 0.375 |
| Reseach & Development Expenses
| 54.922 | 58.249 | 69.537 | 41.371 | 35.918 | 39.215 | 21.348 | 15.579 | 14.049 | 13.467 | 9.021 | 7.54 | 0 |
| General & Administrative Expenses
| 30.437 | 24.386 | 31.535 | 21.3 | 16.072 | 15.799 | 12.21 | 9.85 | 7.599 | 4.93 | 3.952 | 4.243 | 13.608 |
| Selling & Marketing Expenses
| 14.897 | 14.427 | 18.788 | 22.628 | 27.455 | 30.672 | 10.781 | 4.02 | 5.285 | 5.377 | 2.625 | 3.335 | 1.77 |
| SG&A
| 45.334 | 38.812 | 50.323 | 43.928 | 43.527 | 46.472 | 22.991 | 13.87 | 12.883 | 10.307 | 6.576 | 7.578 | 15.378 |
| Other Expenses
| 2.157 | -6.992 | 5.912 | 4.492 | 101.08 | 62.94 | -1.1 | 3.355 | 7.123 | 2.7 | 2.201 | 1.567 | -0 |
| Operating Expenses
| 145.273 | 141.373 | 155.31 | 105.645 | 100.172 | 100.19 | 64.269 | 48.265 | 40.913 | 36.75 | 26.769 | 22.321 | 16.401 |
| Operating Income
| -202.445 | -109.377 | -305.868 | -388.177 | -13.641 | 24.431 | 25.501 | 15.125 | 21.646 | 37.685 | 36.683 | 35.213 | 27.162 |
| Operating Income Ratio
| -0.865 | -0.193 | -0.447 | -0.877 | -0.028 | 0.046 | 0.084 | 0.069 | 0.101 | 0.196 | 0.211 | 0.216 | 0.213 |
| Total Other Income Expenses Net
| 2.157 | 0.008 | 5.912 | 5.992 | 103.08 | 62.94 | -1.1 | 3.343 | 7.119 | 2.693 | 2.168 | 1.526 | -0.042 |
| Income Before Tax
| -200.288 | -109.369 | -299.956 | -382.185 | 89.439 | 87.371 | 24.401 | 18.468 | 28.765 | 40.378 | 38.852 | 36.739 | 27.12 |
| Income Before Tax Ratio
| -0.856 | -0.193 | -0.438 | -0.863 | 0.184 | 0.163 | 0.081 | 0.084 | 0.134 | 0.21 | 0.224 | 0.225 | 0.213 |
| Income Tax Expense
| 16.993 | -11.129 | -1.736 | 1.708 | 17.223 | 15.689 | 1.468 | 2.299 | 3.537 | 5.843 | 5.514 | 5.635 | 3.382 |
| Net Income
| -201.948 | -75.771 | -275.913 | -370.508 | 61.429 | 70.035 | 20.89 | 16.197 | 25.228 | 34.535 | 33.337 | 31.104 | 23.738 |
| Net Income Ratio
| -0.863 | -0.134 | -0.403 | -0.837 | 0.126 | 0.131 | 0.069 | 0.074 | 0.118 | 0.18 | 0.192 | 0.19 | 0.186 |
| EPS
| -0.74 | -0.28 | -1.1 | -1.82 | 0.3 | 0.34 | 0.13 | 0.12 | 0.18 | 0.29 | 0.28 | 0.26 | 0.2 |
| EPS Diluted
| -0.74 | -0.28 | -1.1 | -1.82 | 0.3 | 0.34 | 0.13 | 0.12 | 0.18 | 0.29 | 0.28 | 0.26 | 0.2 |
| EBITDA
| -75.947 | 58.961 | 92.119 | 47.826 | 191.685 | 165.601 | 42.175 | 39.04 | 40.492 | 47.217 | 45.615 | 41.623 | 35.943 |
| EBITDA Ratio
| -0.325 | 0.104 | 0.135 | 0.108 | 0.395 | 0.309 | 0.139 | 0.178 | 0.189 | 0.246 | 0.263 | 0.255 | 0.282 |